Abstract
Financial expenses for psychotropic drugs (analgetics and hypnotics included) used outside of psychiatric hospitals in the German Federal Republic are cited. The use of tranquilizers, neuroleptic and antidepressive drugs inside and outside of psychiatric hospitals is discussed. The author clarifies that the following changes in schizophrenic patients have taken place since the introduction of neuroleptic drugs: the amount of chronically hospitalized schizophrenics has become smaller whereas the number of re-admissions has become considerably bigger compared with the first admissions. The insufficient treatment of schizophrenics after their hospitalization is discussed. Indications and dosage of neuroleptic drugs in schizophrenics are discussed in regard to the author’s definition of a ’’neuroleptic threshold” (weak to strong neuroleptic potency). Clinical-experimental results of the author with 22 different neuroleptic drugs in schizophrenics are discussed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
